Bellon Steven F. 4
4 · Foghorn Therapeutics Inc. · Filed May 27, 2022
Insider Transaction Report
Form 4
Bellon Steven F.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Options (Right to buy)
2022-05-25−675→ 0 totalExercise: $0.73Exp: 2028-01-30→ Common Stock (675 underlying) - Exercise/Conversion
Common Stock
2022-05-25$0.73/sh+675$493→ 116,382 total - Exercise/Conversion
Common Stock
2022-05-25$3.72/sh+3,717$13,827→ 120,099 total - Exercise/Conversion
Stock Options (Right to buy)
2022-05-25−3,717→ 5,574 totalExercise: $3.72Exp: 2029-02-13→ Common Stock (3,717 underlying)
Holdings
- 50,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Shares held by the Steven F. Bellon 2021 Irrevocable Trust dated December 3, 2021, of which the Reporting Person's children are the trustees.
- [F2]The option vested at a rate of 6.25% of the underlying shares beginning on April 1, 2018 and thereafter on the first day of each calendar quarter until the option was fully vested.
- [F3]The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.